Abstract

In response to misaligned sister chromatids during mitosis, the spindle checkpoint protein Mad2 inhibits the anaphase-promoting complex or cyclosome (APC/C) through binding to its mitotic activator Cdc20, thus delaying anaphase onset. Mad1, an upstream regulator of Mad2, forms a tight core complex with Mad2 and facilitates Mad2 binding to Cdc20. In the absence of its binding proteins, free Mad2 has two natively folded conformers, termed N1-Mad2/open-Mad2 (O-Mad2) and N2-Mad2/closed Mad2 (C-Mad2), with C-Mad2 being more active in APC/CCdc20 inhibition. Here, we show that whereas O-Mad2 is monomeric, C-Mad2 forms either symmetric C-Mad2–C-Mad2 (C–C) or asymmetric O-Mad2–C-Mad2 (O–C) dimers. We also report the crystal structure of the symmetric C–C Mad2 dimer, revealing the basis for the ability of unliganded C-Mad2, but not O-Mad2 or liganded C-Mad2, to form symmetric dimers. A Mad2 mutant that predominantly forms the C–C dimer is functional in vitro and in living cells. Finally, the Mad1–Mad2 core complex facilitates the conversion of O-Mad2 to C-Mad2 in vitro. Collectively, our results establish the existence of a symmetric Mad2 dimer and provide insights into Mad1-assisted conformational activation of Mad2 in the spindle checkpoint.

Highlights

  • At the metaphase–anaphase transition, a multisubunit ubiquitin ligase called the anaphase-promoting complex or cyclosome (APC/C) in complex with its mitosis-specific activator Cdc20 mediates the ubiquitination of securin and cyclin B [1,2]

  • Identification of Conformation-Specific Mad2 Mutants We have previously shown that Mad2R133A forms monomeric O-Mad2 and closed Mad2 (C-Mad2) conformers that interconvert with slow kinetics [17]

  • We propose two nonexclusive models to explain why unliganded C-Mad2 is more active in APC/CCdc20 inhibition than O-Mad2 (Figure S6)

Read more

Summary

Introduction

At the metaphase–anaphase transition, a multisubunit ubiquitin ligase called the anaphase-promoting complex or cyclosome (APC/C) in complex with its mitosis-specific activator Cdc mediates the ubiquitination of securin and cyclin B [1,2]. The structures of the Mad monomer and Mad in complex with either Mad or an unnatural peptide ligand called Mad2-binding peptide 1 (MBP1) that mimics the Mad2-binding motifs of Mad or Cdc were determined [11,15,16]. These structures revealed that the Mad monomer has a globular domain and a flexible Cterminal tail. A Mad mutant with its C-terminal tail deleted (Mad2DC) is an open Mad (O-Mad2) monomer, is incapable of binding to Cdc, and inhibits the activity of wild-type Mad in a dominant-negative manner.

Author Summary
Conclusion
Materials and Methods
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.